REMEDY-PILOT

  • Research type

    Research Study

  • Full title

    REDUCING MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ANGINA, ISCHAEMIA AND UNOBSTRUCTED CORONARY ARTERIES – A PILOT STUDY (REMEDY-PILOT)

  • IRAS ID

    295523

  • Contact name

    Cheuk Fung Wong

  • Contact email

    cheuk-fung.wong@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Clinicaltrials.gov Identifier

    NCT05492110

  • Duration of Study in the UK

    3 years, 0 months, 4 days

  • Research summary

    Some patients get chest pain that feels like a heart attack but when tests are done there are no visible problems in the large arteries on the surface of the heart. This condition is called ischaemia with non-obstructed coronary arteries (INOCA). In some INOCA patients, their chest pain may be caused by a problem with the small arteries within the heart muscle, not visible to the naked eye, which under normal conditions change their size in order to control heart blood supply. If abnormal function of the small blood vessels is found, i.e. they have limited ability to open up and increase blood flow, this is termed coronary microvascular dysfunction (CMD).

    We propose a study to test whether implanting a special metal device called a Coronary Sinus Reducer (CS Reducer) will improve the heart’s blood supply and improve patients’ symptoms and quality of life. The CS Reducer is safe and has been shown to help patients with other forms of chest pain. It is thought that the CS Reducer, which narrows the main outlet vein of the heart, will back up blood so that more blood is then available to be re-directed to areas where there is not enough. With more blood reaching the affected areas with reduced blood supply, it is hoped that the frequency and severity of chest pain will reduce, leading to improved quality of life.

    Our study will be the first to test whether implanting the CS Reducer can improve blood supply and reduce chest pain in patients with INOCA and CMD. This initial pilot study will examine if:
    i) we are able to recruit enough participants
    ii) CS Reducer implantation is an acceptable procedure for participants
    iii) CS Reducer implantation can improve blood flow to the heart tested on cardiac MRI and at coronary angiography.

  • REC name

    Scotland B REC

  • REC reference

    22/SS/0014

  • Date of REC Opinion

    29 Apr 2022

  • REC opinion

    Further Information Favourable Opinion